Yuhan Corporation
KRX:000100.KS
Overview | Financials
Company Name | Yuhan Corporation |
Symbol | 000100.KS |
Currency | KRW |
Price | 142,000 |
Market Cap | 10,478,743,882,000 |
Dividend Yield | 0.64% |
52-week-range | 54,285.7 - 166,900 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Wook-Je Cho |
Website | https://www.yuhan.co.kr |
An error occurred while fetching data.
About Yuhan Corporation
Yuhan Corporation, a pharmaceutical company, engages in the research, development, and production of active pharmaceutical products and intermediates in South Korea and internationally. It offers antivirals, antibiotics, antihistamines, antidiabetics, beta-lactamase inhibitors, CNS intermediates, and PEGylated compounds; Revanex, an acid pump antagonist for the treatment of peptic ulcers and gastritis-related mucosal
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD